The pharmaceutical companies in Poland work in the development, distribution, research, and production of quality and affordable pharma products.
Although Poland has a very strong scientific base in life sciences and medicine, it has not really developed dynamic biotechnology or medical technology sector.
Until recently, no really innovative products from Poland were launched on the world market.
The pharmaceutical industry has traditionally relied on generics and, more recently, biosimilars, but the past decade has seen some positive changes and breakthroughs in innovation that are slowly starting to be felt.
Introduction to pharmaceutical companies in Poland
With a population of 38 million people and a healthy and growing economy, Poland is an attractive market for the pharmaceutical industry, which, thanks to the fact that Poland is a member of the European Union, ensures stability and a predictable regulatory environment.
Poland experienced many political and economic changes in 1989 when it began to open up to international cooperation to change its economic and political systems.
This was also the impetus for pharmaceutical cooperation, in which Polish companies use the scientific and medical exchange and join international networks, says Piotr Kolataj, M., Senior Director of Clinical Operations for the Eastern sub-region EMEA, National Director for Poland, Parexel.
Poland is the largest pharmaceutical market in Central and Eastern Europe and the sixth-largest in Europe, while the value of the pharmaceutical market in Poland lags behind that of most Western European countries, it is growing steadily, says Piotr Piotrowski, Ph., Director of Medical Affairs, KCR, an Internati In 2014, IMS Health valued the Polish pharmaceutical market, including pharmacies and hospitals, at 28.7 billion Polish zlotys ($ 775.2 million).
Pharmaceutical Companies in Poland
There are over 493 pharmaceutical companies in Poland but we’ll mention a few, along with their contact information. Here are some of the top pharmaceutical companies in Poland:
A&D Pharma Poland Sp. z o.o.
Address: al. Jerozolimskie 146, 02-305 Warszawa, Poland
Phone: +48 22 570 27 70
Address: Marcina Kasprzaka 31, 01-234 Warszawa, Poland
Phone: +48 22 299 42 02
Alfasigma Poland Sp. o.o.
Address: al. Jerozolimskie 96, 00-807 Warszawa, Poland
Phone: +48 22 824 03 64
ALK-Abelló Poland Sp. z o.o.
Address: al. Pokoju 1, 31-548 Kraków, Poland
Phone: +48 12 348 40 00
Address: Postępu 14, 02-676 Warszawa, Poland
Phone: +48 22 245 73 00
Biofarm Sp. o.o. Polish drug manufacturer
Address: Wałbrzyska 13, 60-198 Poznań, Poland
Phone: +48 61 665 15 00
Bristol-Myers Squibb Poland Sp. o.o.
Address: Aleja Armii Ludowej 26, 00-609 Warszawa, Poland
Phone: +48 22 260 64 00
Cardinal Pharma SA (JSC)
Address: Sowińskiego 5A, 91-485 Łódź, Poland
Phone: +48 42 637 01 47
Chiesi Poland Sp. o.o.
Address: al. Jerozolimskie 134, 02-305 Warszawa, Poland
Phone: +48 22 620 14 21
Address: Rajska 3, 02-654 Warszawa, Poland
Phone: +48 22 266 04 06
Exeltis Poland Sp. Z O.O.
Address: Szamocka 8, 01-748 Warszawa, Poland
Phone: +48 22 822 74 31
EXIM PHARMA SP.ZO.O.
Address: Ogrodowa 37/50, 00-873 Warszawa, Poland
Phone: +48 531 586 600
Genexo Sp z.o.o.
Address: gen. Józefa Zajączka 26, 01-510 Warszawa, Poland
Phone: +48 22 839 11 99
Glenmark Pharmaceuticals Sp. o.o.
Address: Osmańska 14, 02-823 Warszawa, Poland
Phone: +48 22 351 25 00
Ipsen Poland Sp. z o.o.
Address: al. Jana Pawła II 29, 00-867 Warszawa, Poland
Phone: +48 22 653 68 00
Lek SA pharmaceutical plant
Address: Podlipie 16, 95-010 Stryków, Poland
Phone: +48 42 295 71 00
Medpace Poland Sp. z o.o.
Address: Business Garden, Żwirki i Wigury 16C/B4, 02-092 Warszawa, Poland
Phone: +48 22 370 12 70
Noblewell Clinical Research
Address: Iłżecka 26, 02-135 Warszawa, Poland
Phone: +48 22 378 60 00
Omega Pharma Poland Sp. z o.o.
Address: al. Niepodległości 18, 02-653 Warszawa, Poland
Phone: +48 22 489 54 51
Pharma Poland Sp. z o.o.
Address: Mariacka 2/1, 81-383 Gdynia, Poland
Polfa Warszawa SA
Address: Karolkowa 22/24, 01-207 Warszawa, Poland
Phone: +48 22 691 39 00
Ranbaxy Poland Sp. z o.o.
Address: Jakuba Kubickiego 11, 02-954 Warszawa, Poland
Phone: +48 22 642 07 75
Techdow Pharma Poland
Address: Taneczna 18, 02-829 Warszawa, Poland
Phone: +48 22 434 62 00
The Polish pharmaceutical market has an exceptionally high share of generics, says Monika Stefanczyk, Chief Pharmaceutical Market Analyst at PMR Ltd.
The only countries in Central and Eastern Europe with a higher share are Ukraine and Russia, but these countries do not have a modern reimbursement system.
Overall, according to PMR estimates, the share of generics in the total pharmaceutical market (pharmacy and hospital ) taking into account manufacturer prices is at around 70%, while in Romania in the Czech Republic it is 30%, and in the Czech Republic 40%. The reason for this is a very strict reimbursement policy to contain costs.
Although the Polish pharmaceutical market consisted mainly of large-volume generics, several Polish companies have started RandD businesses with a focus on novel, innovative molecules therapies and biosimilars.
In 2013, there were 191 companies in Poland that operated RandD in biotechnology.
Health care costs and access
Health care costs account for 7.4% of Poland’s GDP, which exceeds average spending in the region but is still lower than Western Europe (10%).
Health costs in Poland increased by 50% in 2016 and will exceed $ 40,000 million. A new report from the Ministry of Finance estimates that GDP per capita in Poland will reach 74% of the European Union average by 2022.
Conclusion on the pharmaceutical companies in Poland
Poland ranks second in the most attractive pharmaceutical market in Central and Eastern Europe, only behind the Czech Republic.
The pharmaceutical sector in Poland, one of the most traditional, has changed radically in the last 25 years.
There has been a transition from state to private companies and new regulations have been introduced. The public health management system has changed and market shares were consolidated.
In addition, the importance of foreign pharmaceutical companies as investors in the Polish market has increased.